Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from BML ( (JP:4694) ) is now available.
BML, Inc. has announced corrections to its consolidated earnings report for the first quarter of fiscal 2024 under Japanese GAAP, after discovering errors in previously disclosed numerical data. The revisions mainly affect the company’s reported total assets and equity ratio as of June 30, 2024, and March 31, 2024, while net assets and equity capital figures remain unchanged.
Following the corrections, total assets at the end of the first quarter are now reported as ¥176,267 million, compared with ¥176,384 million at the end of the previous fiscal year, reflecting a modest decline. The equity ratio has been adjusted downward to 71.4% from the previously reported 73.7%, indicating a slightly lower capital adequacy than initially disclosed, though the impact on BML’s overall financial position appears limited.
The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4260.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.
More about BML
BML, Inc. is a Japan-based company listed on the Tokyo Stock Exchange Prime Market under securities code 4694. The company operates in the medical and healthcare services sector, with a focus on diagnostic and laboratory testing solutions that support hospitals, clinics and other healthcare institutions across Japan.
YTD Price Performance: 3.63%
Average Trading Volume: 59,994
Technical Sentiment Signal: Buy
Current Market Cap: Yen149.6B
Find detailed analytics on 4694 stock on TipRanks’ Stock Analysis page.